2013
DOI: 10.1016/j.yexcr.2013.01.015
|View full text |Cite
|
Sign up to set email alerts
|

TGF-α/HA complex promotes tympanic membrane keratinocyte migration and proliferation via ErbB1 receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 48 publications
0
3
0
Order By: Relevance
“…An earlobe fat graft can achieve anatomic and functional success for small perforations, but the results are less satisfactory for large perforations [26][27][28]. Over the past decades, alternatives to resolve the limitations of conventional tympanoplasty have been widely explored [29], including the use of scaffold materials [6], bioactive molecules [5,30] and cells [31,32]. These new technologies should ideally yield more advantages than conventional tympanoplasty.…”
Section: Discussionmentioning
confidence: 99%
“…An earlobe fat graft can achieve anatomic and functional success for small perforations, but the results are less satisfactory for large perforations [26][27][28]. Over the past decades, alternatives to resolve the limitations of conventional tympanoplasty have been widely explored [29], including the use of scaffold materials [6], bioactive molecules [5,30] and cells [31,32]. These new technologies should ideally yield more advantages than conventional tympanoplasty.…”
Section: Discussionmentioning
confidence: 99%
“…Materials and media were used as received, including milled silk powder (average particle size of 5 μm, Smiss Natural, China), chitosan powder (medium molecular weight, Sigma-Aldrich, St. Louis, MO, USA), acetic acid and ethanol (analytical grade, Chem-Supply, Australia), sodium hydroxide (Chem-Supply), two-part silicone elastomer (ACEO, Germany), Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco, MA, USA), fetal bovine serum (FBS, Bovogen, Australia), penicillin (10,000 U/mL) and streptomycin (10 000 g/mL, Aldrich), phosphate buffered saline (PBS, 10 mM, pH 7.4, Aldrich), MTS-kit bioassay (Promega Corporation), triton X-100 (Aldrich), 4,6-diamidino-2-phenylindole (DAPI, Molecular Probes), and Phalloidin Alexa568 (Molecular Probes). Human skin fibroblasts (passage number >20) were used from stock cultures . Cells were incubated in DMEM supplemented with 10% (v/v) FBS, 1% (v/v) penicillin and 1% (v/v) streptomycin in a humidified atmosphere of 5% CO 2 at 37 °C.…”
Section: Methodsmentioning
confidence: 99%
“…The use of cultured cells for treatment of patients with chronic otitis was reported in 1997 (Somers et al 1997), but since then, there have been no reports on clinical use. However, an increasing number of papers have described culturing of TMKs for the purpose of potential transplantation (Levin et al 2009;Mei Teh et al 2013). The rationale for cell therapy must be dependent on the presence of TM-specific stem cells, and consequently that a stem cell deficiency may prevent regeneration.…”
Section: Introductionmentioning
confidence: 99%